Overview

Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of different doses of etanercept for the treatment of moderate to severe psoriasis.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Etanercept